Paper39735677
Deep learning identification of novel autophagic protein-protein interactions and experimental validation of Beclin 2-Ubiquilin 1 axis in triple-negative breast cancer.
Li X and 6 others. Oncol Res, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Deep learning identification of novel autophagic protein-protein interactions and experimental validation of Beclin 2-Ubiquilin 1 axis in triple-negative breast cancer. Papers, record 39735677. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39735677
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Deep learning identification of novel autophagic protein-protein interactions and experimental validation of Beclin 2-Ubiquilin 1 axis in triple-negative breast cancer.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Triple Negative Breast Neoplasms | Major topic |
| Autophagy | Major topic |
| Protein Interaction Maps | Major topic |
| Humans | |
| Female | |
| Cell Line, Tumor | |
| Molecular Docking Simulation | |
| Cell Proliferation | |
| Adaptor Proteins, Signal Transducing |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36864290 | Autophagy and autophagy-related pathways in cancer. | Nat Rev Mol Cell Biol | 2023 | https://conductscience.org/library/papers/36864290 | PubMed |
| 2 | 31114890 | Protein Interaction Z Score Assessment (PIZSA): an empirical scoring scheme for evaluation of protein-protein interactions. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/31114890 | PubMed |
| 3 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 4 | 20877296 | Triple-negative breast cancer: disease entity or title of convenience? | Nat Rev Clin Oncol | 2010 | https://conductscience.org/library/papers/20877296 | PubMed |
| 5 | 25797270 | Systems biology network-based discovery of a small molecule activator BL-AD008 targeting AMPK/ZIPK and inducing apoptosis in cervical cancer. | Oncotarget | 2015 | https://conductscience.org/library/papers/25797270 | PubMed |
| 6 | 36103432 | User Identification Across Multiple Social Networks Based on Naive Bayes Model. | IEEE Trans Neural Netw Learn Syst | 2024 | https://conductscience.org/library/papers/36103432 | PubMed |
| 7 | 23954414 | Beclin 2 functions in autophagy, degradation of G protein-coupled receptors, and metabolism. | Cell | 2013 | https://conductscience.org/library/papers/23954414 | PubMed |
| 8 | 36527769 | Diabetes disease detection and classification on Indian demographic and health survey data using machine learning methods. | Diabetes Metab Syndr | 2023 | https://conductscience.org/library/papers/36527769 | PubMed |
| 9 | 36038913 | Recent advances in therapeutic strategies for triple-negative breast cancer. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/36038913 | PubMed |
| 10 | 35872332 | Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options. | Pharmacol Ther | 2022 | https://conductscience.org/library/papers/35872332 | PubMed |
| 11 | 34754128 | Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. | Nat Rev Clin Oncol | 2022 | https://conductscience.org/library/papers/34754128 | PubMed |
| 12 | 27137187 | The recognition of ubiquitinated proteins by the proteasome. | Cell Mol Life Sci | 2016 | https://conductscience.org/library/papers/27137187 | PubMed |
| 13 | 34094830 | Multi-omics approaches identify SF3B3 and SIRT3 as candidate autophagic regulators and druggable targets in invasive breast carcinoma. | Acta Pharm Sin B | 2021 | https://conductscience.org/library/papers/34094830 | PubMed |
| 14 | 22455463 | clusterProfiler: an R package for comparing biological themes among gene clusters. | OMICS | 2012 | https://conductscience.org/library/papers/22455463 | PubMed |
| 15 | 32459143 | Selective autophagy of MHC-I promotes immune evasion of pancreatic cancer. | Autophagy | 2020 | https://conductscience.org/library/papers/32459143 | PubMed |
| 16 | 35073169 | Pathogenesis of Triple-Negative Breast Cancer. | Annu Rev Pathol | 2022 | https://conductscience.org/library/papers/35073169 | PubMed |
| 17 | 34761267 | The IntAct database: efficient access to fine-grained molecular interaction data. | Nucleic Acids Res | 2022 | https://conductscience.org/library/papers/34761267 | PubMed |
| 18 | 30395287 | UniProt: a worldwide hub of protein knowledge. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30395287 | PubMed |
| 19 | 17671126 | Triple-negative breast cancer: clinical features and patterns of recurrence. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17671126 | PubMed |
| 20 | 34455870 | Strategies for targeting undruggable targets. | Expert Opin Drug Discov | 2022 | https://conductscience.org/library/papers/34455870 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BECN2 | 441925 | PubTator's text mining | https://conductscience.org/library/genes/441925 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| UBQLN1 | 29979 | PubTator's text mining | https://conductscience.org/library/genes/29979 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39735677
GET https://conductscience.org/api/papers/v1/39735677/references?page=2